November 1, 2016 Gregg Beloff, Principal Danforth Advisors, LLCCerulean Pharma Inc. • November 3rd, 2016 • Pharmaceutical preparations
Research Collaboration AgreementResearch Collaboration Agreement • November 3rd, 2016 • Cerulean Pharma Inc. • Pharmaceutical preparations • New York
Research Collaboration Agreement (“Agreement”), dated October 18, 2016 (the “Effective Date”), between Novartis Institutes for BioMedical Research, Inc. (“Novartis”) and Cerulean Pharma Inc. (“Cerulean”). Novartis and Cerulean are each separately referred to as a “Party” and are collectively referred to as the “Parties”.
